Innovative approaches to cervical cancer screening in low- and middle-income countries

References

• Fitzmaurice C, Dicker D, Pain A, et al. The global burden of cancer 2013. JAMA Oncol 2015;1:505–27
   PubMed Web of Science ®Google Scholar
• LaVigne AW, Triedman SA, Randall TC, Trimble EL, Viswanathan AN. Cervical cancer in low and middle income countries: addressing barriers to radiotherapy delivery. Gynecol Oncol Rep 2017;22:16–20
   PubMed Web of Science ®Google Scholar
• Forman D, de Martel C, Lacey CJ, et al. Global burden of human papillomavirus and related diseases. Vaccine 2012;30(Suppl 5):F12–F23
   PubMed Web of Science ®Google Scholar
• Obel J, Souares Y, Hoy D, et al. A systematic review of cervical cancer incidence and mortality in the Pacific Region. Asian Pac J Cancer Prev 2014;15:9433–7
   PubMedGoogle Scholar
• Qiao YL, Jeronimo J, Zhao FH, et al. Lower cost strategies for triage of human papillomavirus DNA-positive women. Int J Cancer 2014;134:2891–901
   PubMed Web of Science ®Google Scholar
• World Health Organization. WHO Guidelines for screening and treatment of precancerous lesions for cervical cancer prevention. Geneva: World Health Organization Press; 2013
   Google Scholar
• Catarino R, Petignat P, Dongui G, Vassilakos P. Cervical cancer screening in developing countries at a crossroad: emerging technologies and policy choices. World J Clin Oncol 2015;6:281–90
   PubMed Web of Science ®Google Scholar
• Holme F, Kapambwe S, Nessa A, Basu P, Murillo R, Jeronimo J. Scaling up proven innovative cervical cancer screening strategies: challenges and opportunities in implementation at the population level in low- and lower-middle-income countries. Int J Gynaecol Obstet 2017;138(Suppl 1):63–8
   PubMed Web of Science ®Google Scholar
• Varghese C, Carlos MC, Shin HR. Cancer burden and control in the Western Pacific region: challenges and opportunities. Ann Glob Health 2014;80:358–69
   PubMed Web of Science ®Google Scholar
• Nanda K, McCrory DC, Myers ER, et al. Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review. Ann Intern Med 2000;132:810–19
   PubMed Web of Science ®Google Scholar
• Landy R, Pesola F, Castañón A, Sasieni P. Impact of cervical screening on cervical cancer mortality: estimation using stage-specific results from a nested case–control study. Br J Cancer 2016;115:1140–6
   PubMed Web of Science ®Google Scholar
• Vallely A, Mola GD, Kaldor JM. Achieving control of cervical cancer in Papua New Guinea: what are the research and program priorities? P N G Med J 2011;54:83–90
   PubMedGoogle Scholar
• Bigoni J, Gundar M, Tebeu PM, et al. Cervical cancer screening in sub-Saharan Africa: a randomized trial of VIA versus cytology for triage of HPV-positive women. Int J Cancer 2015;137:127–34
   PubMed Web of Science ®Google Scholar
• Sauvaget C, Fayette JM, Muwonge R, Wesley R, Sankaranarayanan R. Accuracy of visual inspection with acetic acid for cervical cancer screening. Int J Gynaecol Obstet 2011;113:14–24
   PubMed Web of Science ®Google Scholar
• Basu P, Nessa A, Majid M, Rahman JN, Ahmed T. Evaluation of the national cervical cancer screening programme of Bangladesh and the formulation of quality assurance guidelines. J Fam Plann Reprod Health Care 2010;36:131–4
   PubMed Web of Science ®Google Scholar
• Ngoma T, Muwonge R, Mwaiselage J, Kawegere J, Bukori P, Sankaranarayanan R. Evaluation of cervical visual inspection screening in Dar es Salaam, Tanzania. Int J Gynaecol Obstet 2010;109:100–4
   PubMed Web of Science ®Google Scholar
• Chumworathayi B, Blumenthal PD, Limpaphayom KK, Kamsa-Ard S, Wongsena M, Supaatakorn P. Effect of single-visit VIA and cryotherapy cervical cancer prevention program in Roi Et, Thailand: a preliminary report. J Obstet Gynaecol Res 2010;36:79–85
   PubMed Web of Science ®Google Scholar
• Basu P, Mittal S, Banerjee D, et al. Diagnostic accuracy of VIA and HPV detection as primary and sequential screening tests in a cervical cancer screening demonstration project in India. Int J Cancer 2015;137:859–67
   PubMed Web of Science ®Google Scholar
• Cuzick J, Arbyn M, Sankaranarayanan R, et al. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries. Vaccine 2008;26(Suppl 10):K29–K41
   PubMed Web of Science ®Google Scholar
• Fokom-Domgue J, Combescure C, Fokom-Defo V, et al. Performance of alternative strategies for primary cervical cancer screening in sub-Saharan Africa: systematic review and meta-analysis of diagnostic test accuracy studies. BMJ 2015;351:h3084
   PubMed Web of Science ®Google Scholar
• Davis-Dao CA, Cremer M, Felix J, Cortessis VK. Effect of cervicitis on visual inspection with acetic acid. J Low Genit Tract Dis 2008;12:282–6
   PubMed Web of Science ®Google Scholar
• Denny L, Kuhn L, Pollack A, Wright TC Jr, Direct visual inspection for cervical cancer screening: an analysis of factors influencing test performance. Cancer 2002;94:1699–707
   PubMed Web of Science ®Google Scholar
• Vallely AJ, Toliman PJ, Ryan C, et al. Association between visual inspection of the cervix with acetic acid examination and high-risk human papillomavirus infection, chlamydia trachomatis, neisseria gonorrhoeae and trichomonas vaginalis in Papua New Guinea. Aust N Z J Obstet Gynaecol 2018; doi: 10.1111/ajo.12783. [Epub ahead of print]
   PubMedGoogle Scholar
• Dillner J, Rebolj M, Birembaut P, et al. Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study. BMJ 2008;337:a1754
   PubMed Web of Science ®Google Scholar
• Patanwala IY, Bauer HM, Miyamoto J, Park IU, Huchko MJ, Smith-McCune KK. A systematic review of randomized trials assessing human papillomavirus testing in cervical cancer screening. Am J Obstet Gynecol 2013;208:343–53
   PubMed Web of Science ®Google Scholar
• Ronco G, Dillner J, Elfstrom KM, et al. Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials. Lancet 2014;383:524–32
   PubMed Web of Science ®Google Scholar
• Lorenzi AT, Fregnani JH, Possati-Resende JC, et al. Can the careHPV test performed in mobile units replace cytology for screening in rural and remote areas?. Cancer Cytopathol 2016;124:581–8
   PubMed Web of Science ®Google Scholar
• Zhao FH, Jeronimo J, Qiao YL, et al. An evaluation of novel, lower-cost molecular screening tests for human papillomavirus in rural China. Cancer Prev Res 2013;6:938–48
   PubMed Web of Science ®Google Scholar
• Broquet C, Triboullier D, Untiet S, Schafer S, Petignat P, Vassilakos P. Acceptability of self-collected vaginal samples for HPV testing in an urban and rural population of Madagascar. Afr Health Sci 2015;15:755–61
   PubMed Web of Science ®Google Scholar
• Gravitt PE, Rositch AF. HPV self-testing and cervical cancer screening coverage. Lancet Oncol 2014;15:128–9
   PubMed Web of Science ®Google Scholar
• Arbyn M, Verdoodt F, Snijders PJ, et al. Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis. Lancet Oncol 2014;15:172–83
   PubMed Web of Science ®Google Scholar
• Kelly H, Mayaud P, Segondy M, Pant Pai N, Peeling RW. A systematic review and meta-analysis of studies evaluating the performance of point-of-care tests for human papillomavirus screening. Sex Transm Infect 2017;93(Suppl 4):S36–S45
   Web of Science ®Google Scholar
• Ying H, Jing F, Fanghui Z, Youlin Q, Yali H. High-risk HPV nucleic acid detection kit-the careHPV test -a new detection method for screening. Sci Rep 2014;4:4704
   PubMed Web of Science ®Google Scholar
• Castle PE, Smith KM, Davis TE, et al. Reliability of the Xpert HPV assay to detect high-risk human papillomavirus DNA in a colposcopy referral population. Am J Clin Pathol 2015;143:126–33
   PubMed Web of Science ®Google Scholar
• Einstein MH, Smith KM, Davis TE, et al. Clinical evaluation of the cartridge-based GeneXpert human papillomavirus assay in women referred for colposcopy. J Clin Microbiol 2014;52:2089–95
   PubMed Web of Science ®Google Scholar
• Toliman P, Badman SG, Gabuzzi J, et al. Field evaluation of Xpert HPV point-of-care test for detection of human papillomavirus infection by use of self-collected vaginal and clinician-collected cervical specimens. J Clin Microbiol 2016;54:1734–7
   PubMedGoogle Scholar
• Toliman PJ, Kaldor JM, Badman SG, et al. Evaluation of self-collected vaginal specimens for the detection of high-risk HPV infection and the prediction of high-grade cervical intraepithelial lesions in a high-burden, low-resource setting. Clin Microbiol Infect 2018; in press
   Google Scholar
• Toliman P, Kaldor J, Badman SG, et al. Point-of-care Xpert HPV Test outperforms visual inspection with acetic acid, and a combination HPV/VIA algorithm, for the detection of high-grade cervical disease in Papua New Guinea. Presented at the Australasian Tropical Health Conference; 9–11 November, 2017, Cairns, Australia
   Google Scholar
• Kunckler M, Schumacher F, Kenfack B, et al. Cervical cancer screening in a low-resource setting: a pilot study on an HPV-based screen-and-treat approach. Cancer Med 2017;6:1752–61
   PubMed Web of Science ®Google Scholar
• Tebeu PM, Fokom-Domgue J, Crofts V, et al. Effectiveness of a two-stage strategy with HPV testing followed by visual inspection with acetic acid for cervical cancer screening in a low-income setting. Int J Cancer 2015;136:E743–50
   PubMed Web of Science ®Google Scholar
• Chibwesha CJ, Frett B, Katundu K, et al. Clinical performance validation of 4 point-of-care cervical cancer screening tests in HIV-infected women in Zambia. J Low Genit Tract Dis 2016;20:218–23
   PubMed Web of Science ®Google Scholar
• Lorincz AT. Virtues and weaknesses of DNA methylation as a test for cervical cancer prevention. Acta Cytol 2016;60:501–12
   PubMed Web of Science ®Google Scholar
• De Strooper LM, van Zummeren M, Steenbergen RD, et al. CADM1, MAL and miR124-2 methylation analysis in cervical scrapes to detect cervical and endometrial cancer. J Clin Pathol 2014;67:1067–71
   PubMed Web of Science ®Google Scholar
• Clarke MA, Luhn P, Gage JC, et al. Discovery and validation of candidate host DNA methylation markers for detection of cervical precancer and cancer. Int J Cancer 2017;141:701–10
   PubMed Web of Science ®Google Scholar
• Kocsis A, Takacs T, Jeney C, et al. Performance of a new HPV and biomarker assay in the management of hrHPV positive women: subanalysis of the ongoing multicenter TRACE clinical trial (n > 6,000) to evaluate POU4F3 methylation as a potential biomarker of cervical precancer and cancer. Int J Cancer 2017;140:1119–33
   PubMed Web of Science ®Google Scholar
• Leal SM, Jr, Gulley ML. Current and emerging molecular tests for human papillomavirus-related neoplasia in the genomic era. J Mol Diagn 2017;19:366–77
   PubMed Web of Science ®Google Scholar
• Del Mistro A, Frayle H, Rizzi M, et al. Methylation analysis and HPV genotyping of self-collected cervical samples from women not responding to screening invitation and review of the literature. PLoS One 2017;12:e0172226
   PubMed Web of Science ®Google Scholar